Goodbody Health Stock Canadian Securities Exchange
Equities
SWEL
CA3821591011
Pharmaceuticals
Sales 2020 | 1.99M 2.46M 3.38M | Sales 2021 | 17.06M 21.08M 28.88M | Capitalization | 13.76M 17M 23.3M |
---|---|---|---|---|---|
Net income 2020 | -4M -4.94M -6.77M | Net income 2021 | -2M -2.47M -3.39M | EV / Sales 2020 | 5.41 x |
Net cash position 2020 | 1.37M 1.7M 2.32M | Net cash position 2021 | 5.73M 7.08M 9.7M | EV / Sales 2021 | 0.47 x |
P/E ratio 2020 |
-1.4
x | P/E ratio 2021 |
-5.64
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 70.26% |
Managers | Title | Age | Since |
---|---|---|---|
George Thomas
CEO | Chief Executive Officer | 35 | 21-01-25 |
Geremy Thomas
FOU | Founder | 64 | 11-02-13 |
John Pettit
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Geremy Thomas
FOU | Founder | 64 | 11-02-13 |
George Thomas
CEO | Chief Executive Officer | 35 | 21-01-25 |
Anne Tew
SEC | Corporate Secretary | - | 18-10-31 |
1st Jan change | Capi. | |
---|---|---|
+39.54% | 6.12B | |
-16.47% | 4.44B | |
-10.16% | 3.14B | |
-0.71% | 3.03B | |
-1.06% | 2.57B | |
+40.09% | 1.87B | |
-0.76% | 1.63B | |
-11.19% | 1.62B | |
-12.74% | 1.53B |